SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.11-2.6%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (9018)9/1/2003 10:50:16 AM
From: Elmer  Read Replies (2) of 52153
 
To Peter, Richard, MZ, Ice et al

A friend's sister has Multiple Sclerosis. Her physician has recently recommended treatment with Rebif.

I know that there are may drugs for treatment of the symptoms of MS but only a few that are disease modifying drugs including interferon beta Ia (Avonex and Rebif), interferon beta Ib (Betaseron) and Glatiramer acetate (Copaxone).

Do you know of any ongoing clinical trials for new disease modifying drugs for MS? Any help will again be very appreciated. You guys are terrifically generous with your knowledge.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext